November 25, 2019     Acute Ischemic Stroke Guidelines Updated With Comprehensive Recommendations The American Heart Association (AHA)/American Stroke Association (ASA) has issued an update to the 2018 guidelines for the early management of acute ischemic stroke, clarifying prior recommendations and taking into consideration new clinical trial data. Read more   Satralizumab BLA Accepted by FDA for Treatment of NMOSD The FDA has accepted Genentech’s biologics license application (BLA) for satralizumab based on findings from 2 phase 3 trials that showed effectiveness in reducing risk of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD). Read more